Mohammed Haneefa Nizamudeen/iStock via Getty Images
Intercept Pharmaceuticals, which agreed to be sold to Alfasigma late last month, dropped 4% amid a new report from the European Medicines Agency.
The study failed to show that Ocaliva was more effective than placebo (a dummy treatment) in terms of the number of